Skip to main content
Top
Published in: International Urogynecology Journal 11/2017

01-11-2017 | Original Article

Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?

Authors: Stefan Mohr, Christine Marthaler, Sara Imboden, Ash Monga, Michel D. Mueller, Annette Kuhn

Published in: International Urogynecology Journal | Issue 11/2017

Login to get access

Abstract

Introduction and hypothesis

Mixed urinary incontinence (MUI), defined as mixed symptoms of stress urinary incontinence (SUI) and overactive bladder (OAB), is a difficult entity if conservative treatment has failed. Cure rates are low compared with SUI, particularly the OAB component, may deteriorate after sling insertion. Bulking agents pose an appealing alternative for the treatment of MUI. They have shown beneficial effect in small case studies, but larger series are lacking. The aim of this prospective study was an analysis of treatment efficacy and safety profile of the bulking agent, Bulkamid, in female patients with MUI.

Methods

One hundred fifty-four women with MUI symptoms (components of SUI/OAB within the limits of 60–40% either way) received bulking therapy with polyacrylamide hydrogel (Bulkamid). Patients were followed-up 3 months postoperatively. Primary outcome was the domain Incontinence impact on the King’s Health Questionnaire (KHQ). Secondary outcomes were the other KHQ domains, visual analog scale (VAS), and International Continence Society (ICS) standardized pad weight test as objective measurement of incontinence.

Results

Statistically significant improvements were found for all KHQ domains, pad weight test, and the visual analog scale (VAS) before and after bulking. Overall complication rate was 13%.

Conclusions

This study has shown improvement in MUI after bulking therapy according to both subjective and objective outcomes. We can advocate bulking therapy for treating MUI, as it is simple and safe and shows both objective and subjective improvement and relief. Long-term results (up to 1 year) are awaited.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26. doi:10.1007/s00192-009-0976-9.CrossRefPubMed Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26. doi:10.​1007/​s00192-009-0976-9.CrossRefPubMed
4.
go back to reference Kammerer-Doak D, Rizk DE, Sorinola O, Agur W, Ismail S, Bazi T. Mixed urinary incontinence: international urogynecological association research and development committee opinion. Int Urogynecol J. 2014;25:1303–12. doi:10.1007/s00192-014-2485-8.CrossRefPubMed Kammerer-Doak D, Rizk DE, Sorinola O, Agur W, Ismail S, Bazi T. Mixed urinary incontinence: international urogynecological association research and development committee opinion. Int Urogynecol J. 2014;25:1303–12. doi:10.​1007/​s00192-014-2485-8.CrossRefPubMed
8.
9.
go back to reference Aigmueller T, Bjelic-Radisic V, Kargl J, Hinterholzer S, Laky R, Trutnovsky G, Kolovetsiou-Kreiner V, Tamussino K. Reasons for dissatisfaction ten years after TVT procedure. Int Urogynecol J. 2014;25:213–7. doi:10.1007/s00192-013-2213-9.CrossRefPubMed Aigmueller T, Bjelic-Radisic V, Kargl J, Hinterholzer S, Laky R, Trutnovsky G, Kolovetsiou-Kreiner V, Tamussino K. Reasons for dissatisfaction ten years after TVT procedure. Int Urogynecol J. 2014;25:213–7. doi:10.​1007/​s00192-013-2213-9.CrossRefPubMed
11.
12.
go back to reference Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104:1374–9.CrossRefPubMed Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104:1374–9.CrossRefPubMed
13.
go back to reference Bjelic-Radisic V, Dorfer M, Tamussino K, Greimel E. Psychometric properties and validation of the German-language King’s health questionnaire in women with stress urinary incontinence. Neurourol Urodyn. 2005;24:63–8. doi:10.1002/nau.20092.CrossRefPubMed Bjelic-Radisic V, Dorfer M, Tamussino K, Greimel E. Psychometric properties and validation of the German-language King’s health questionnaire in women with stress urinary incontinence. Neurourol Urodyn. 2005;24:63–8. doi:10.​1002/​nau.​20092.CrossRefPubMed
15.
go back to reference Ryhammer AM, Djurhuus JC, Laurberg S. Pad testing in incontinent women: a review. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10:111–5.CrossRefPubMed Ryhammer AM, Djurhuus JC, Laurberg S. Pad testing in incontinent women: a review. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10:111–5.CrossRefPubMed
16.
go back to reference Mouritsen L, Lose G, Moller-Bek K. Long-term follow-up after urethral injection with polyacrylamide hydrogel for female stress incontinence. Acta Obstet Gynecol Scand. 2014;93:209–12. doi:10.1111/aogs.12283.CrossRefPubMed Mouritsen L, Lose G, Moller-Bek K. Long-term follow-up after urethral injection with polyacrylamide hydrogel for female stress incontinence. Acta Obstet Gynecol Scand. 2014;93:209–12. doi:10.​1111/​aogs.​12283.CrossRefPubMed
17.
go back to reference Leone Roberti MU, Bogani G, Meschia M, Sorice P, Braga A, Salvatore S, Ghezzi F, Serati M. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015;189:48–54. doi:10.1016/j.ejogrb.2015.03.025.CrossRef Leone Roberti MU, Bogani G, Meschia M, Sorice P, Braga A, Salvatore S, Ghezzi F, Serati M. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015;189:48–54. doi:10.​1016/​j.​ejogrb.​2015.​03.​025.CrossRef
19.
go back to reference Pai A, Al-Singary W. Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid((R))) in the management of stress and mixed urinary incontinence: three year follow up outcomes. Cent Eur J Urol. 2015;68:428–33. doi:10.5173/ceju.2015.647.CrossRef Pai A, Al-Singary W. Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid((R))) in the management of stress and mixed urinary incontinence: three year follow up outcomes. Cent Eur J Urol. 2015;68:428–33. doi:10.​5173/​ceju.​2015.​647.CrossRef
20.
go back to reference Kasi AD, Pergialiotis V, Perrea DN, Khunda A, Doumouchtsis SK. Polyacrylamide hydrogel (Bulkamid(R)) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J. 2016;27:367–75. doi:10.1007/s00192-015-2781-y.CrossRefPubMed Kasi AD, Pergialiotis V, Perrea DN, Khunda A, Doumouchtsis SK. Polyacrylamide hydrogel (Bulkamid(R)) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J. 2016;27:367–75. doi:10.​1007/​s00192-015-2781-y.CrossRefPubMed
23.
go back to reference Zimmern PE, Gormley EA, Stoddard AM, Lukacz ES, Sirls L, Brubaker L, Norton P, Oliphant SS, Wilson T. Management of recurrent stress urinary incontinence after burch and sling procedures. Neurourol Urodyn. 2016;35:344–8. doi:10.1002/nau.22714.CrossRefPubMed Zimmern PE, Gormley EA, Stoddard AM, Lukacz ES, Sirls L, Brubaker L, Norton P, Oliphant SS, Wilson T. Management of recurrent stress urinary incontinence after burch and sling procedures. Neurourol Urodyn. 2016;35:344–8. doi:10.​1002/​nau.​22714.CrossRefPubMed
25.
go back to reference Zivanovic I, Rautenberg O, Lobodasch K, von Bünau G, Walser C, Viereck V. Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure. Neurourol Urodyn. 2016; doi:10.1002/nau.23007.PubMed Zivanovic I, Rautenberg O, Lobodasch K, von Bünau G, Walser C, Viereck V. Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure. Neurourol Urodyn. 2016; doi:10.​1002/​nau.​23007.PubMed
27.
28.
go back to reference Krhut J, Martan A, Jurakova M, Nemec D, Masata J, Zvara P. Treatment of stress urinary incontinence using polyacrylamide hydrogel in women after radiotherapy: 1-year follow-up. Int Urogynecol J. 2016;27:301–5. doi:10.1007/s00192-015-2834-2.CrossRefPubMed Krhut J, Martan A, Jurakova M, Nemec D, Masata J, Zvara P. Treatment of stress urinary incontinence using polyacrylamide hydrogel in women after radiotherapy: 1-year follow-up. Int Urogynecol J. 2016;27:301–5. doi:10.​1007/​s00192-015-2834-2.CrossRefPubMed
30.
go back to reference Kotb AF, Campeau L, Corcos J. Urethral bulking agents: techniques and outcomes. Curr Urol Rep. 2009;10:396–400.CrossRefPubMed Kotb AF, Campeau L, Corcos J. Urethral bulking agents: techniques and outcomes. Curr Urol Rep. 2009;10:396–400.CrossRefPubMed
Metadata
Title
Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?
Authors
Stefan Mohr
Christine Marthaler
Sara Imboden
Ash Monga
Michel D. Mueller
Annette Kuhn
Publication date
01-11-2017
Publisher
Springer London
Published in
International Urogynecology Journal / Issue 11/2017
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-017-3332-5

Other articles of this Issue 11/2017

International Urogynecology Journal 11/2017 Go to the issue

Urogynecology Digest

Urogynecology digest